Share Buyback

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

ProCap Financial is making waves, buying 450 Bitcoin while aggressively repurchasing its own stock to close a valuation gap. A new corporate playbook?

A class action lawsuit alleges hospital operator Ardent Health misled investors by hiding financial risks, leading to a 33% stock price collapse.

The kefir pioneer unveils a muscle-building drink and probiotic butter, leveraging strong financials to capture a share of the $75B cultured dairy boom.

Following a historic $2B revenue year, Tradeweb's CEO will address institutional investors, focusing on AI, digital assets, and global market expansion.

The waste giant is renewing its massive share repurchase program and adding a special tool to help its biggest institutional investors cash out.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.

Bolstered by strong 2025 earnings, Extendicare is acquiring CBI Home Health to dominate Canada's home care market while boosting shareholder returns.

Nuveen Churchill Direct Lending Corp. adjusts its shareholder return strategy in response to a changing interest rate and spread environment.

The burger chain posted robust revenue and a massive jump in annual net income, outperforming rivals and detailing plans for major global expansion.

The energy giant unveils a massive capital plan to boost regulated assets, even as a $471M write-down on renewables reveals significant grid challenges.

The energy giant is using a complex financial tool to fund major projects. We break down what it means for investors and the future of the power grid.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

Asbury Automotive nets $210M from strategic dealership sales, funneling capital into debt reduction and a massively expanded share repurchase program.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

The secure identity firm beat Wall Street estimates with accelerating revenue and record cash flow, signaling major growth and increased shareholder returns.

The certification giant posts 6.5% organic growth, rewarding investors while doubling down on sustainability, renewables, and cybersecurity acquisitions.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.